ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
PowerShares Exchange Traded Fund Trust PowerShares FTSE

PowerShares Exchange Traded Fund Trust PowerShares FTSE (PRFZS)

61,460,000.00
50,000.00
(0.08%)
Closed August 10 4:00PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
61,460,000.00
Price Change
50,000.00
Change %
0.08%
Name
PowerShares Exchange Traded Fund Trust PowerShares FTSE
Symbol
PRFZS
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Bid
61,410,000.00
Ask
61,410,000.00
Open
-
High
0.00
Low
0.00
Close
61,460,000.00
Previous Close
61,410,000.00
Market
NASDAQ Indices
Type
Index

PRFZS Latest News

Deltagen Reports 2014 Full Year Financial Results

Deltagen, Inc. (Pink Sheets: DGEN), a provider of drug discovery tools and services to the biopharmaceutical industry, today reported unaudited consolidated financial results for the year...

Deltagen Reports 2013 First Quarter Financial Results

Deltagen, Inc. (Pink Sheets: DGEN), a provider of drug discovery tools and services to the biopharmaceutical industry, today reported unaudited consolidated financial results for the three...

Deltagen Reports 2012 Fourth Quarter and Full-Year Financial Results

Deltagen, Inc. (Pink Sheets: DGEN), a leading provider of drug discovery tools and services to the biopharmaceutical industry, today reported unaudited consolidated financial results for...

Deltagen Reports 2012 Third Quarter Financial Results

Deltagen, Inc. (Pink Sheets: DGEN), a leading provider of drug discovery tools and services to the biopharmaceutical industry, today reported unaudited consolidated financial results for...

Deltagen Reports 2012 Second Quarter Financial Results

Deltagen, Inc. (Pink Sheets: DGEN), a leading provider of drug discovery tools and services to the biopharmaceutical industry, today reported unaudited consolidated financial...

Deltagen Reports 2012 First Quarter Financial Results

Deltagen, Inc. (Pink Sheets:DGEN), a leading provider of drug discovery tools and services to the biopharmaceutical industry, today reported unaudited consolidated financial...

Deltagen Reports 2011 Fourth Quarter and Full-Year Financial Results

Deltagen, Inc. (Pink Sheets: DGEN), a leading provider of drug discovery tools and services to the biopharmaceutical industry, today reported unaudited consolidated financial...

Deltagen Reports 2011 Third Quarter Financial Results and Announces Funding for Deltagen BioServices, Inc.

Deltagen, Inc. (Pink Sheets:DGEN), a leading provider of drug discovery tools to the biopharmaceutical industry, today reported unaudited consolidated financial results for the...

Deltagen Reports 2011 Second Quarter Financial Results

Deltagen, Inc. (Pink Sheets: DGEN), a leading provider of drug discovery tools to the biopharmaceutical industry, today reported unaudited consolidated financial results for the...

Deltagen Reports 2011 First Quarter Financial Results

Deltagen, Inc. (Pink Sheets:DGEN), a leading provider of drug discovery tools to the biopharmaceutical industry, today reported unaudited consolidated financial results for the...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000IX
40000000IX
120000000IX
260000000IX
520000000IX
1560000000IX
2600000000IX
Indices
Commodities
Forex
US5005,329.9023.400.44%
US3039,570.00118.000.30%
US1002,560.5014.300.56%
DJI39,497.5451.050.13%
SP5005,344.1624.850.47%
COMPX16,745.3085.280.51%
DXY102.5130.000.00%

Your Recent History

Delayed Upgrade Clock